Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CCCC | Stock Option (Right to Buy) | Disposed to Issuer | $0 | -115K | -100% | $0.00* | 0 | Mar 7, 2024 | Common Stock | 115K | $33.23 | Direct | F1, F2 |
transaction | CCCC | Stock Option (Right to Buy) | Award | $0 | +115K | $0.00 | 115K | Mar 7, 2024 | Common Stock | 115K | $19.00 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | On March 7, 2024, the Compensation Committee of the Issuer's Board of Directors approved an option repricing. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. |
F2 | 25% of the shares underlying this option shall vest and become exercisable on January 3, 2023, with the remainder vesting in twelve equal quarterly installments thereafter. |